search
Back to results

Remission of Type 2 Diabetes Via Calorie Restriction

Primary Purpose

Type 2 Diabetes, Obesity, Morbid

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Calorie restriction via total food replacement
Sponsored by
Yeouido St. Mary's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Type 2 diabetes If you have been diagnosed with diabetes within the last 6 years and have been treated for diabetes for more than 3 months Glycated hemoglobin was measured as less than 9% without insulin treatment for the last 3 months Body mass index of 25kg/m2 or more Exclusion Criteria: Pregnant women Target organ failure such as heart failure, liver failure, kidney failure, and chronic obstructive disease History of cardiovascular disease and cancer and current treatment Acute infection or acute treatment requiring hospitalization such as surgery within the last 3 months Any medications that may affect blood sugar within the last 6 months Food allergies

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    Normal diet

    Low-calorie diet

    Arm Description

    Standard medical therapy for type 2 diabetes

    Korean low-calorie diet for type 2 diabetes

    Outcomes

    Primary Outcome Measures

    Remission
    It is defined as a case where the HbA1c measured at the end of the 12-week intervention after stopping the drug was less than 6.5%.

    Secondary Outcome Measures

    Weight loss
    It is defined as a case where the weight loss more than 10% at the end of the 12-week intervention

    Full Information

    First Posted
    February 20, 2023
    Last Updated
    April 25, 2023
    Sponsor
    Yeouido St. Mary's Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05754775
    Brief Title
    Remission of Type 2 Diabetes Via Calorie Restriction
    Official Title
    Type 2 Diabetes Remission Induced by a Korean Low-calorie Diet: A Single Center Pilot Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    June 1, 2023 (Anticipated)
    Primary Completion Date
    February 28, 2024 (Anticipated)
    Study Completion Date
    February 28, 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Yeouido St. Mary's Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The primary purpose was to evaluate the efficacy of Korean low-calorie diet for obese adult patients with type 2 diabetes with a body mass index of 25 kg/m2 or higher.
    Detailed Description
    Previous studies reporting the natural course of type 2 diabetes generally reported progressive worsening of the disease. However, several recent studies suggested that significant weight loss induced by an very-low calorie diet could lead to the improvement in glycemic control that enough to drug discontinuation. Considering that improvement in diabetes is not permanent and hyperglycemia may recur, American and European expert groups define and express the improvement of diabetes as "remission". In several studies in the Western contries, remission was confimed in patients who achieved significant weight loss with a daily intake of less than 800 kcal consisting of powder with high protein ingredients. When 11 patients with the disease were given only 600 kcal daily for 8 weeks, fasting blood glucose significantly decreased within 7 days. (Diabetologia 2011; 54: 2506-14). In a follow-up study, dietary intervention for 8 weeks was applied to 30 patients, about 40% of the patients showed remission of diabetes. (Diabetes Care 2016; 39: 158-65). Based on this small study, a primary care-based research group in the United Kingdom recruited obese diabetic patients from private clinics across the country and evaluated the diabetic remission effect of a very-low caloric diet in a total of 306 patients. In this study, 46% of the intervention group and 4% of the non-intervention group reported remission, confirming a significant difference in remission rates. Patients who achieved more weight loss in the intervention group had higher remission rates, with a remission rate of 57% for patients who lost 10 to 15 kg and a remission rate of 86% for patients who lost more than 15 kg. (Lancet 2018; 391: 541-51). On the other hand, in Korea, a study has been conducted using a Korean traditional foods designed by clinical nutritionists for diabetic patients that delivers to home. When continuous blood glucose measurement was performed while the special diet program was provided for 2 weeks, mean blood glucose and estimated glycated hemoglobin during the treatment diet period decreased compared to the free food period. The effect of the Korean-style diabetic diet was thought to be mainly due to the decrease in blood glucose levels after meals (J Korean Diabetes 2020;21:46-54). In previous studies, total food replacement for calorie restriction was only attempted in the form of powder. In the case of the Korean diet, it contains a sufficient amount of dietary fiber and has the advantage of maintaining appropriate clinical nutrition therapy by providing various textures and tastes. Therefore, the investigators planned a clinical study to induce remission with a low-calorie diet using the Korean diet as a meal replacement therapy for calorie restriction in Korean patients with type 2 diabetes.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Type 2 Diabetes, Obesity, Morbid

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Normal diet
    Arm Type
    No Intervention
    Arm Description
    Standard medical therapy for type 2 diabetes
    Arm Title
    Low-calorie diet
    Arm Type
    Experimental
    Arm Description
    Korean low-calorie diet for type 2 diabetes
    Intervention Type
    Behavioral
    Intervention Name(s)
    Calorie restriction via total food replacement
    Intervention Description
    Restricted foods designed by a clinical nutritionist that delivers to home for diabetic patients.
    Primary Outcome Measure Information:
    Title
    Remission
    Description
    It is defined as a case where the HbA1c measured at the end of the 12-week intervention after stopping the drug was less than 6.5%.
    Time Frame
    The glycated hemoglobin level in percentage measured 12 weeks after the study screening date was used.
    Secondary Outcome Measure Information:
    Title
    Weight loss
    Description
    It is defined as a case where the weight loss more than 10% at the end of the 12-week intervention
    Time Frame
    The body weight in kilograms measured 12 weeks after the study screening date was used.

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Type 2 diabetes If you have been diagnosed with diabetes within the last 6 years and have been treated for diabetes for more than 3 months Glycated hemoglobin was measured as less than 9% without insulin treatment for the last 3 months Body mass index of 25kg/m2 or more Exclusion Criteria: Pregnant women Target organ failure such as heart failure, liver failure, kidney failure, and chronic obstructive disease History of cardiovascular disease and cancer and current treatment Acute infection or acute treatment requiring hospitalization such as surgery within the last 3 months Any medications that may affect blood sugar within the last 6 months Food allergies
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jinyoung Kim
    Phone
    821099710039
    Email
    julia@catholic.ac.kr
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Hyuk-Sang Kwon
    Organizational Affiliation
    Yeouido St. Mary's Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Remission of Type 2 Diabetes Via Calorie Restriction

    We'll reach out to this number within 24 hrs